Due to the high mortality associated with recent, widely circulating strains of H5N1 influenza
virus in poultry, the recurring introduction of H5N1 viruses from birds to humans, and the …

Options for the control of emerging and reemerging H5N1 influenza viruses include
improvements in biosecurity and the use of inactivated vaccines. Commercially available …

An inactivated H5N1 avian influenza (AI) vaccine generated by reverse genetics and
containing the hemagglutinin and neuraminidase genes of the H5N1 A/goose/Guangdong/1 …

Avian influenza A H5N1 viruses similar to those that infected humans in Hong Kong in 1997
continue to circulate in waterfowl and have reemerged in poultry in the region, raising …

In light of the recurrent outbreaks of low pathogenic avian influenza (LPAI) and highly
pathogenic avian influenza (HPAI), there is a pressing need for the development of vaccines …

Recent outbreaks of highly pathogenic avian influenza A virus (H5N1 subtype) infections in
poultry and humans (through direct contact with infected birds) have raised concerns that a …

In 2003, an outbreak of highly pathogenic avian influenza occurred in the Netherlands. The
avian H7N7 virus causing the outbreak was also detected in 88 humans suffering from …

H5N1 influenza viruses have spread extensively among wild birds and domestic poultry.
Cross-species transmission of these viruses to humans has been documented in over 380 …

In the present study, we explored the genetic basis underlying the virulence and host range
of two H5N1 influenza viruses in chickens. A/goose/Guangdong/1/96 (GS/GD/1/96) is a …

Several live attenuated influenza virus A/California/7/09 (H1N1)(CA09) candidate vaccine
variants that possess the hemagglutinin (HA) and neuraminidase (NA) gene segments from …